TPEX/4147 (TPEX/4147)

Taipei Exchange: TPEX/4147 · TWD

NT$60.3

-0.70 (-1.1%)· Recorded snapshot

Market cap	16.5B
Revenue (ttm)	619.5M
Net income (ttm)	-138.9M
EPS (ttm)	-NT$0.51
Shares out	273.2M
Volume	444,847
Beta	-0.07

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 619.5M
Net income (ttm): -138.9M
EPS (ttm): -NT$0.51
Market cap: 16.5B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-3.7

P25 n/aP50 n/aP75 n/a

ROIC-2.7

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All TPEX/4147 indicators

Market & fundamental data

Available fields

198

Groups with data

Currency

TWD

Showing 198 of 198 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	TWD
Country	Taiwan
Country code	TW
Earnings date	2026-11-13
Enterprise value	TWD 15.3B
Exchange	Taipei Exchange
Financial currency	TWD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	2007
Industry	Biotechnology
Is primary listing	Yes
ISIN number	TW0004147004
Last earnings date	2025-11-12
Last refreshed	2026-10-28
Market cap	TWD 16.5B
Next earnings date	2026-11-13
Price	TWD 60.30
Price currency	TWD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	tpex/4147
Website	https://www.taimedbiologics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-0.85%
EV/FCF	142.1x
EV/Sales	24.78x
FCF / EV yield	0.7%
FCF yield	0.66%
Industry forward P/E	174.47x
P/(FCF - SBC) ratio	172.37x
P/(OCF - SBC) ratio	115.46x
P/B ratio	4.48x
P/FCF ratio	152.53x
P/OCF ratio	106.2x
P/S ratio	26.59x
Price / tangible book value	5.02x
Sector forward P/E	28.08x
Sector P/E	83.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-30.27%
EBITDA margin	-6.31%
FCF margin	17.43%
Gross margin	45.77%
Operating margin	-30.27%
Pretax margin	-22.42%
Profit margin	-22.42%
ROA	-2.52%
ROA (5Y)	-3.52%
ROCE	-4.36%
ROE	-3.66%
ROE (5Y)	-8.42%
ROIC	-2.73%
SBC / revenue	2.01%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	4
FCF growth (Q)	1,379.4%
Gross profit growth	16.3%
Gross profit growth (Q)	17.15%
Gross profit growth 3Y	5.22%
Gross profit growth 5Y	-3.94%
Net income growth years	1
OCF growth (Q)	1,323.3%
Revenue growth	3.58%
Revenue growth (Q)	13.3%
Revenue growth (QoQ)	-6.17%
Revenue growth 10Y	93.77%
Revenue growth 3Y	1.12%
Revenue growth 5Y	2.38%
Revenue growth quarters	1
Revenue growth years	2

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	TWD -47.1M
Depreciation and amortization	TWD 148.4M
EBIT	TWD -187.5M
EBITDA	TWD -39.1M
EPS	TWD -0.51
FCF per share	TWD 0.40
Financing cash flow	TWD -164.5M
Free cash flow	TWD 108M
Free cash flow minus SBC	TWD 95.6M
Gross profit	TWD 283.5M
Investing cash flow	TWD 288.5M
Net borrowing	TWD -29.8M
Net cash flow	TWD 292.9M
Net income	TWD -138.9M
Operating cash flow minus SBC	TWD 142.7M
Operating income	TWD -187.5M
Revenue	TWD 619.5M
Stock-based compensation	TWD 12.4M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	13.28
Book value per share	TWD 13.46
Debt / equity	0.13
Debt / FCF	4.43
Interest coverage	-18.03
Long-term assets	TWD 1.4B
Long-term liabilities	TWD 626.9M
Net cash (debt)	TWD 1.1B
Net cash / market cap	6.84%
Net cash growth	-1.1%
Net debt / equity	-0.31
Net debt / FCF	-10.43
Piotroski F-Score	5
Property, plant and equipment	TWD 812.2M
Shareholders' equity	TWD 3.7B
Tangible book value	TWD 3.3B
Tangible book value per share	TWD 12.02
Total assets	TWD 4.5B
Total cash	TWD 1.6B
Total debt	TWD 478.1M
Total liabilities	TWD 824.5M
WACC	3.78%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.13
Current assets	TWD 3.1B
Current liabilities	TWD 197.6M
Current ratio	15.48
Inventory turnover	0.24
Net working capital	TWD 1.3B
Quick ratio	8.63
Working capital	TWD 2.9B
Working capital turnover	0.21

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	0.22%
Shareholder yield	0.22%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-69.35%
10Y return CAGR	-11.03%
10Y total return	-68.9%
150-day SMA	TWD 58.03
15Y price change	54.82%
15Y return CAGR	3.21%
15Y total return	60.55%
1D price change	-1.15%
1M price change	-1.77%
1M total return	-1.77%
1W price change	-0.65%
1W total return	-0.65%
1Y price change	-16.78%
1Y return CAGR	-16.79%
1Y total return	-16.78%
20-day SMA	TWD 61.40
200-day SMA	TWD 57.69
3M price change	4.1%
3M total return	4.1%
3Y price change	-27.38%
3Y return CAGR	-9.68%
3Y total return	-26.33%
50-day SMA	TWD 62.54
50-day SMA vs 200-day SMA	50over200
52-week high	TWD 75.40
52-week high date	2026-07-06
52-week low	TWD 47.00
52-week low date	2026-05-28
5Y price change	-7.01%
5Y return CAGR	-1.16%
5Y total return	-5.66%
6M price change	26.29%
6M total return	26.29%
All-time high	TWD 349.50
All-time high date	2018-05-03
All-time low	TWD 1.05
All-time low date	2015-07-02
Average true range (ATR)	TWD 2.12
Average volume	816.6K
Beta (1Y)	-0.11
Beta (2Y)	0.14
Beta (5Y)	-0.07
Change from 52-week high	-20.03%
Change from 52-week low	28.3%
Change from all-time high	-82.55%
Change from all-time low	5,709.52%
Change from open	-1.95%
Day's gap	0.82%
Dollar volume	TWD 26.8M
High price	TWD 61.50
Low price	TWD 60.10
Monthly RSI	44.78
Open price	TWD 61.50
Position in 52-week range	14.29%
Previous close	TWD 61.00
Price vs 150-day SMA	5.13%
Price vs 20-day SMA	-0.64%
Price vs 200-day SMA	5.73%
Price vs 50-day SMA	-2.47%
Relative volume	0.54
RSI	48.36
Sharpe ratio	-0.27
Sharpe ratio (3Y)	-0.25
Sharpe ratio (5Y)	0.08
Sortino ratio	-0.29
Sortino ratio (3Y)	-0.22
Sortino ratio (5Y)	0.27
Volume	444.8K
Weekly RSI	50.8
YTD price change	-0.33%
YTD total return	-0.33%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	182.1M
Shares change (QoQ)	-0.79%
Shares change (YoY)	-0.22%
Shares held by insiders	1.55%
Shares held by institutions	5.16%
Shares outstanding	273.2M

Deeper analysis on TPEX/4147

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this TPEX/4147 report

Is a complete TPEX/4147 research report available?

No complete published report is available for tpex/4147 (TPEX/4147) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

TPEX/4147 (TPEX/4147)

Price

Financial snapshot

Fair-value bridge

Latest news · TPEX/4147

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TPEX/4147 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on TPEX/4147

Frequently asked questions